Drug Approval | May 27, 2023
Eugia Pharma receives USFDA approval for Carboprost Tromethamine Injection
The product is expected to be launched in June 2023
The product is expected to be launched in June 2023
The company has reported total income of Rs. 11303.95 crores during the period ended March 31, 2023
The addition of these two hospitals will provide increased access to specialized pediatric and perinatal care services in the geography
Wider reach for nutraceuticals portfolio in Europe, Turkey and Egypt
The certification issued by the EDQM verifies the compliance of pharmaceutical substances
The collaboration between CORONA and Ferring will cater to patients across India
New agreement applies to the polymers of the Medical Care series portfolio
Net profit for FY23 at Rs. 140 crore as compared to Rs. 166 crore in FY22
Specialty Chemicals grew 38% YoY for FY23
Revenue from operations at Rs 512.81 crores registered a growth of 17% Y-o-Y for full year FY23
Subscribe To Our Newsletter & Stay Updated
